Galderma has secured FDA approval for Restylane Contour for temple hollowing, a structural filler indication that targets age-related volume loss in the temporal region. This approval expands Restylane's footprint in the premium contouring space, where practitioners command higher per-syringe fees for anatomically precise, three-dimensional work.
Injectables
Galderma Wins FDA Approval for Restylane Contour — Temple Indication Expands Structural Filler Segment
New indication for temple volume restoration adds a high-skill, high-margin treatment to Restylane's portfolio.
1-YEAR MOVE
ABBV
▲11.6%
| Ticker | Company | 1-year change |
|---|---|---|
| ABBV | AbbVie (Allergan Aesthetics) | +11.6% |
Temple treatment is a high-skill procedure that justifies premium pricing and attracts experienced injectors.
Temple treatment is a high-skill procedure—improper placement risks vascular compromise and blindness—which means it attracts experienced injectors and justifies premium pricing. Restylane Contour's approval gives you a branded, cleared option for a procedure many practices currently perform off-label with other HA fillers. The indication also sits within Galderma's loyalty and rebate infrastructure, likely tied to Restylane's broader bundling strategy. For practices already deep in Restylane, this is an easy add; for those weighted toward AbbVie, it's a competitive pressure point that may shift your per-unit acquisition cost.
Source: original report ↗
Frequently asked questions
Is Restylane Contour FDA approved for temples?
Yes, Galderma recently secured FDA approval for Restylane Contour for temple hollowing and age-related volume loss in the temporal region. This is a new indication that expands Restylane's structural filler portfolio beyond previous approved uses.
Why is temple filler treatment considered high-skill?
Temple injections require anatomically precise, three-dimensional placement because improper needle placement risks vascular compromise and blindness. This high-risk profile means the procedure attracts experienced injectors who can command premium per-syringe fees.
What's the margin difference between temple filler and standard filler treatments?
Temple treatments are positioned as high-margin procedures because practitioners can charge premium per-syringe fees for the specialized anatomical knowledge and skill required. The exact margin varies by practice, but the structural nature and complexity justify higher pricing than standard facial filler work.
Should I switch to Restylane Contour if I'm currently doing temple fillers off-label?
The FDA approval gives you a branded, cleared option for a procedure many practices already perform off-label with other HA fillers. If you're already in Restylane's loyalty or rebate program, adding this indication is an easy upsell; if you're weighted toward AbbVie products, this may create competitive pressure on your per-unit acquisition costs.
How does the Restylane temple approval affect pricing strategy?
The approval sits within Galderma's loyalty and rebate infrastructure, likely tied to Restylane's broader bundling strategy. Practices already committed to Restylane may see bundled pricing incentives, while this new indication could shift per-unit costs for practices considering a switch from competitors.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.